These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7549521)

  • 1. Effect of RANTES on intracellular expression of EG2 antigen in eosinophils.
    Kakazu T; Chihara J; Saito A; Higashimoto I; Yamamoto T; Kurachi D; Nakajima S
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():43-4. PubMed ID: 7549521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of cytokine RANTES on induction of activated eosinophils].
    Kakazu T; Chihara J; Saito A; Nakajima S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1226-32. PubMed ID: 8583714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of RANTES on eosinophil adhesion to plates coated with recombinant soluble intercellular adhesion molecule-1 and expression of beta 2-integrin adhesion molecules on eosinophils.
    Kakazu T; Chihara J; Saito A; Nakajima S
    Int Arch Allergy Immunol; 1995; 108 Suppl 1():9-11. PubMed ID: 7549527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF.
    Kapp A; Zeck-Kapp G; Czech W; Schöpf E
    J Invest Dermatol; 1994 Jun; 102(6):906-14. PubMed ID: 7516398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RANTES is a chemotactic and activating factor for human eosinophils.
    Alam R; Stafford S; Forsythe P; Harrison R; Faubion D; Lett-Brown MA; Grant JA
    J Immunol; 1993 Apr; 150(8 Pt 1):3442-8. PubMed ID: 7682241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GM-CSF analogue E21R induces apoptosis of normal and activated eosinophils.
    Iversen PO; Robinson D; Ying S; Meng Q; Kay AB; Clark-Lewis I; Lopez AF
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1628-32. PubMed ID: 9372686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANTES augments radical oxygen products from eosinophils.
    Chihara J; Hayashi N; Kakazu T; Yamamoto T; Kurachi D; Nakajima S
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):52-3. PubMed ID: 7512397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tests for bronchial asthma].
    Adachi T; Chihara J
    Rinsho Byori; 2000 Dec; 48(12):1125-9. PubMed ID: 11215421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prednisolone on eosinophils, IL-5, eosinophil cationic protein, EG2+ eosinophils, and nitric oxide metabolites in the sputum of patients with exacerbated asthma.
    Jang AS; Choi IS; Koh YI; Jeong TK; Lee KY; Kim YS; Lee JU; Park CS
    J Korean Med Sci; 2000 Oct; 15(5):521-8. PubMed ID: 11068988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of blood EG2+ eosinophils in patients with bronchial asthma.
    Monteseirín J; Llamas E; Muñoz F; Bono MJ; Conde J
    Allergol Immunopathol (Madr); 1993; 21(3):97-9. PubMed ID: 8356938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemically stained activated eosinophils in sputum in patients with asthma.
    Jang AS; Choi IS; Park CS
    Respiration; 2000; 67(2):183-8. PubMed ID: 10773791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins.
    Nakajima H; Loegering DA; Kita H; Kephart GM; Gleich GJ
    J Leukoc Biol; 1999 Sep; 66(3):447-54. PubMed ID: 10496315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-blood flow-cytometric analysis of eosinophil EG2 expression as a marker of the pathological conditions of asthma.
    Kuwasaki T; Chihara J; Kayaba H; Kamata Y; Oyamada H; Saito N; Shioya T; Sasaki M; Kagaya M; Tsuda A
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():77-80. PubMed ID: 9758904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunofluorescence analysis of cytokine and granule protein expression during eosinophil maturation from cord blood-derived CD34 progenitors.
    Mahmudi-Azer S; Velazquez JR; Lacy P; Denburg JA; Moqbel R
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1178-84. PubMed ID: 10856153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANTES augments eosinophil lucigenin-dependent chemiluminescence.
    Chihara J; Kakazu T; Higashimoto I; Saito N; Honda K; Tsuda A; Kayaba H; Kamada Y; Oyamada H; Urayama O
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():40-3. PubMed ID: 9758895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil activation in allergic disease.
    Venge P; Håkansson L; Peterson CG
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):333-7. PubMed ID: 3553024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein.
    Ying S; Meng Q; Taborda-Barata L; Corrigan CJ; Barkans J; Assoufi B; Moqbel R; Durham SR; Kay AB
    Eur J Immunol; 1996 Jan; 26(1):70-6. PubMed ID: 8566086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The changes of EG1 and EG2 positive eosinophils and their clinical significance in asthmatics].
    Huang H; Xu J; Zhong N
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):612-4. PubMed ID: 11477881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the cytokine RANTES released from platelets as an eosinophil chemotactic factor.
    Kameyoshi Y; Schröder JM; Christophers E; Yamamoto S
    Int Arch Allergy Immunol; 1994; 104 Suppl 1(1):49-51. PubMed ID: 7512396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eosinophil activation evaluated by using a anti-human secreted form of ECP antibody (EG2)].
    Kobayashi H; Maeda S; Tamura M; Sakamoto S
    Nihon Rinsho; 1993 Mar; 51(3):626-30. PubMed ID: 8492435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.